Alcohol consumption, smoking and drug use are some of the most common practices worldwide, given the easy access to these products, lower government restrictions as well as authorized production. The World Health Organization says that over 3 million deaths every year are the result of excessive intake of alcohol. Addiction to drugs, tobacco and alcohol has also been rising among teenagers and women in line with evolving lifestyle and easy availability. A number of researches show that close to 50 disorders are associated with over consumption of these substances, including liver cirrhosis, cancer, depression, immune suppression and dementia. The rise in these disorders across the world has raised the demand for effective substance abuse treatment options.​

Market Research Future (MRFR) believes that the substance abuse treatment market can capture a healthy growth rate of 11.6% over the analysis period (from 2018 to 2023).

The Clinical and Translational Investigation journal’s report in 2015 claimed that over 60% of smokers begin smoking at 13 years of age while more than 90% of the total population starts before they reach 20 years of age. Sensing the burgeoning numbers of substance abusers across the countries, pharmaceutical firms are launching new drugs that help curb the craving among patients. Disulfiram happens to be one of the earliest drugs in the market that controls the acetaldehyde dehydrogenase enzyme and is widely used in alcohol abuse treatment.

Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/7230

Other growth rendering factors include technological innovations in the diagnostics sector, soaring awareness among patients about the available treatment options and the surge in treatment rates as well as improving healthcare infrastructure.

Competitive Analysis

INSYS Therapeutics, Amphastar Pharmaceuticals, Opiant Technologies, Teva Pharmaceuticals, Mylan Laboratories, Glenmark, Sterinova, Allergan, Sun Pharmaceuticals, Sanquin, Lupin, Apotex, BioCorRx, Cipla, Forest Laboratories, Inc., Alkermes Plc, LFB Group, Accord Healthcare, Purdue Pharma LP, Pfizer Inc., Reckitt Benckiser Pharmaceuticals, Sanofi Aventis, and GlaxoSmithKline Plc. are key players of the global substance abuse treatment market.

Segmentation

The global substance abuse treatment market is segmented based on Abuse Type, Treatment Type, and End user.

The global market for substance abuse treatment, by Abuse Type is segmented into drug abuse, alcohol dependence, and tobacco/nicotine addiction. The drug abuse segment is anticipated to hold the largest market share owing to the increasing addiction of opioid. According to the National Institute of Drug Abuse, nearly 90 million Americans have died due to opioid abuse.
The market, by Treatment Type, is segmented into alcohol addiction treatment, tobacco/nicotine addiction treatment, and drug abuse treatment. The alcohol addiction treatment segment is further classified into naltrexone, disulfiram, and acamprosate. The tobacco/nicotine addiction treatment segment is further classified into nicotine replacement treatment and non-nicotine medication. The nicotine replacement treatment segment includes nicotine spray, nicotine patch, nicotine lozenge, nicotine gum, and nicotine inhaler. The non-nicotine medication segment includes bupropion, and varenicline. The drug abuse treatment segment is further classified as methadone, buprenorphine, and naltrexone.
Based on End user, the market is segmented into inpatient treatment centers, outpatient treatment centers, and residential treatment centers.
Regional Analysis

Asia Pacific/APAC, Americas, MEA or Middle East & Africa and Europe are the key markets for substance abuse treatment worldwide.

The Americas is spearheading the global market for substance abuse treatment, in view of the soaring number of drug awareness campaigns as well as prevention programs. These campaigns cover spreading awareness among patients to boost the treatment-seeking rate. Rising government intervention with significant funds and initiatives to control distribution of illicit drugs and other substances also favor the regional market. Other growth enhancing factors include burgeoning population of substance abusers and the surge in technical advancements.

Get Access Full Report @ https://www.marketresearchfuture.com/reports/substance-abuse-treatment-market-7230

Asia Pacific shows the potential to attain the fastest growth rate in the years to come, thanks to the growing efforts by several countries to deal with mounting concerns regarding drug and alcohol abuse. Moreover, government across various countries are spending considerably on promotional campaigns to prevent and treat addiction. Surge in tobacco addiction coupled with the rise in technical advances also elevate the market position in the region. Alcohol dependency and opioid abuse are quite rampant in the region, especially among the lower-class population while mental health issues have become major concerns. This is bound to create a lucrative scenario for the substance abuse treatment market in the coming years.